NCT03363997View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

December 15, 2016

Study Completion Date

June 6, 2017

Conditions
Menopause
Interventions
DRUG

Estriol 0.125 mg/day

Application of one vaginal ring

DRUG

Estriol 0.250 mg/day

Application of one vaginal ring

DRUG

Estriol 0.500 mg/day

Application of one vaginal ring

Trial Locations (1)

Unknown

Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas

All Listed Sponsors
collaborator

SocraTec R&D GmbH

OTHER

lead

Galeno Desenvolvimento de Pesquisas Clínicas

OTHER_GOV

NCT03363997 - Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days | Biotech Hunter | Biotech Hunter